Brazilian approval of Sputnik V vaccine delayed by missing data

In a statement on the Health Ministry's website, regulator Anvisa said the request failed to provide adequate assurances on Phase III clinical trials and issues related to the manufacture of the vaccine. Uniao Quimica is seeking approval for the use of 10 million doses of Sputnik V in Brazil in the first quarter of this year.

Reuters | Updated: 17-01-2021 15:16 IST | Created: 17-01-2021 14:46 IST
Brazilian approval of Sputnik V vaccine delayed by missing data
Representative Image Image Credit: ANI

Brazil's health regulator is seeking further data on Russia's Sputnik V coronavirus vaccine before considering its approval for emergency use.

Documents supporting drugmaker Uniao Quimica's application for emergency use of the vaccine have been returned to the company because they did not meet its minimum criteria, the watchdog said on Saturday. In a statement on the Health Ministry's website, regulator Anvisa said the request failed to provide adequate assurances on Phase III clinical trials and issues related to the manufacture of the vaccine.

Uniao Quimica is seeking approval for the use of 10 million doses of Sputnik V in Brazil in the first quarter of this year. Russia's RDIF sovereign wealth fund, which is promoting Sputnik globally, on Sunday said that Anvisa had requested additional information that would be provided shortly.

Its statement said that such requests from regulators were standard procedure and do not mean the registration bid has been rejected. It also said that legislation going through the Brazilian Senate, if approved, would allow use of vaccines approved by other countries. Moscow has approved Sputnik for Russian domestic use, though clinical trials there have not yet been completed.

Anvisa officials had previously said that the Sputnik V vaccine would have to be submitted to Phase III clinical trials in Brazil before its use could be authorised. Anvisa said on Saturday that any applicant requesting emergency use authorisation must show that the vaccine would deliver long-term safety and effectiveness.

The regulator is expected to make a decision on Sunday about authorising emergency use of vaccines developed by China's Sinovac and Britain's AstraZeneca. RDIF said that Sputnik had already been registered in Serbia, Belarus, Argentina, Bolivia, Algeria, Venezuela, Paraguay and by the Palestinian authorities.

Registrations in two more countries are expected next week, it said.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

US STOCKS-Wall Street ends sharply lower, tech selloff weighs as bond yields climb

Wall Streets main indexes tumbled on Thursday, with the Nasdaq index posting its largest daily percentage fall in four months, as technology-related stocks remained under pressure following a rise in U.S. bond yields. The Dow and the SP 500...

Biden USTR nominee Tai vows to end trade 'race to the bottom,' counter China

Katherine Tai, President Joe Bidens top trade nominee, backed tariffs as a legitimate tool to counter Chinas state-driven economic model and vowed to hold Beijing to its prior commitments, while promising a sweeping new approach to U.S. tra...

Tesla to cut Model 3 production in U.S. for two weeks - sources

Electric vehicle maker Tesla Inc plans to slash production of its Model 3 sedans for two weeks, sources told Reuters on Thursday, at a time when demand is slowing for Tesla cars and the market faes a chip shortage.They were not aware of the...

Tough U.S. climate stance could help Canada defy critics, boost emissions targets

U.S. President Joe Bidens aggressive stance on tackling climate change is likely to help Canada overcome resistance in its western oil patch as it aims to beef up its own greenhouse gas emissions targets, a move critics say is long overdue....

Give Feedback